|
Volumn 51, Issue 2, 2005, Pages 98-102
|
The use of corticosteroid as treatment in SARS was associated with adverse outcomes: A retrospective cohort study
|
Author keywords
Coronavirus; Corticosteroid; Outcome; SARS; Severe acute respiratory syndrome
|
Indexed keywords
BETA LACTAM ANTIBIOTIC;
CORTICOSTEROID;
HYDROCORTISONE;
IMMUNOGLOBULIN G;
LACTATE DEHYDROGENASE;
LOPINAVIR PLUS RITONAVIR;
MACROLIDE;
METHYLPREDNISOLONE;
RIBAVIRIN;
VIRUS ANTIBODY;
ADULT;
AGE;
AGED;
ARTICLE;
CLINICAL FEATURE;
COHORT ANALYSIS;
COMORBIDITY;
DEMOGRAPHY;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
FEMALE;
HIGH RISK PATIENT;
HONG KONG;
HOSPITAL ADMISSION;
HUMAN;
INTENSIVE CARE UNIT;
LABORATORY TEST;
LACTATE DEHYDROGENASE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTIPLE REGRESSION;
MULTIVARIATE ANALYSIS OF COVARIANCE;
NONHUMAN;
PROGNOSIS;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
SIDE EFFECT;
VIRUS PNEUMONIA;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
AGED, 80 AND OVER;
COHORT STUDIES;
DEMOGRAPHY;
DRUG COMBINATIONS;
FEMALE;
HONG KONG;
HUMANS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
ODDS RATIO;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SEVERE ACUTE RESPIRATORY SYNDROME;
TREATMENT OUTCOME;
|
EID: 22144463826
PISSN: 01634453
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jinf.2004.09.008 Document Type: Article |
Times cited : (190)
|
References (10)
|